Dose–exposure–IGF-I response of once-weekly somapacitan in adults with GH deficiency
Sign Up to like & getrecommendations! Published in 2022 at "European Journal of Endocrinology"
DOI: 10.1530/eje-21-1167
Abstract: Objective Growth hormone (GH) replacement therapy in patients with adult growth hormone deficiency (AGHD) is individually titrated due to variable dose–responses among patients. The aim of this study was to provide clinical guidance on dosing… read more here.
Keywords: exposure igf; somapacitan; dose exposure; igf response ... See more keywords